​

Pomdoctor Stock (NASDAQ:POM)


RevenueFinancialsChart

Previous Close

$1.62

52W Range

$0.43 - $102.42

50D Avg

$1.13

200D Avg

$2.74

Market Cap

$12.19M

Avg Vol (3M)

$2.05M

Beta

2.28

Div Yield

-

POM Company Profile


Pomdoctor Limited, operating through its various divisions, runs an e-commerce platform for the direct sale of pharmaceutical products to consumers. The company is actively developing an online healthcare services platform specifically designed for managing long-term illnesses within the Chinese market. Its primary emphasis is on chronic disease care and pharmaceutical provision, facilitating a digital portal that connects patients with medical professionals and essential medications. Pomdoctor's operations largely encompass both a virtual hospital model and a comprehensive pharmaceutical supply chain, thus linking individual users, pharmacies, distributors, medical experts, and other healthcare stakeholders. This enterprise was established in 2010 and is headquartered in Guangzhou, China.

Show More

Industry

Medical - Pharmaceuticals

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CN

Employees

165

IPO Date

Oct 08, 2025

Website

POM Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 25
Other Operating Segment$399.91M

Fiscal year ends in Dec 24 | Currency in CNY

POM Financial Summary


Dec 24Dec 23Dec 22
Revenue$342.56M$304.85M$245.22M
Operating Income$-25.79M$-22.25M$-3.59M
Net Income$-143.36M$-145.39M$-125.51M
EBITDA$-24.27M$-22.99M$-3.81M
Basic EPS$-1.21$-1.23$-1.06
Diluted EPS$-1.21$-1.23$-1.06

Fiscal year ends in Dec 24 | Currency in CNY

Peer Comparison


TickerCompany
AIRSAirSculpt Technologies, Inc.
AQSTAquestive Therapeutics, Inc.
ERASErasca, Inc.
AVXLAnavex Life Sciences Corp.
SIBNSI-BONE, Inc.
CTMXCytomX Therapeutics, Inc.
INNVInnovage Holding Corp.
OFIXOrthofix Medical Inc.
PACBPacific Biosciences of California, Inc.
FLGTFulgent Genetics, Inc.